Trial Profile
Open-label, phase II, single-group, multicentre study of idiotypic vaccination in patients with follicular lymphoma in first relapse
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Dasiprotimut T (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.